Total Funding
67
60
Total FundingVenture - Series Unknown raised
Growth Score
-11 pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
5069
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
- Zhen Li: Co-Founder, President, and CEOPast Role: Arrowhead Pharmaceuticals, Senior Vice President
- Hubert Chen: Chief Medical OfficerPast Role: Metacrine, Chief Medical Officer
About the Company
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts. It discovers and develops innovative therapeutics that can utilize a family of endogenous enzymes called adenosine deaminase acting on RNA (ADAR) to precisely target and correct single point mutations on an mRNA, thus the production of desired and
functional protein is restored.
Women Founded
Women Led
